Frontlight ResearchEarly access
Trial site
The Second Affiliated Hospital Of Xi'an Jiaotong University (Xibei Hospital)
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma3 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- Psoriasis1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 1/24 trials
- Phase 33 trials
- Phase 42 trials
- Status
- Recruiting4 trials
- Not yet recruiting3 trials
- Completed2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 trials
- Hangzhou Sumgen Biotech Co., Ltd.2 trials
- Chipscreen Biosciences, Ltd.1 trial
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1 trial
- Fudan University1 trial
- and 3 more
Running trials
Recruiting
To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma
Not yet recruiting
Recruiting
Recruiting
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Recruiting
Recruiting
A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma3 recruiting
- Colorectal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Psoriasis1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026